U.S. cardiovascular company IPOs 2006-2023

Published by
Matej Mikulic,
Dec 10, 2024
illustrated is the total number of initial public offerings (IPOs) for R&D stage therapeutic companies active in cardiovascular diseases and disorders in the U.S. from 2006 to 2023. In 2023, one cardiovascular company went public.

Number of initial public offerings (IPOs) for cardiovascular companies in the U.S. from 2006 to 2023

Loading statistic...

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2024

Region

United States

Survey time period

2006 to 2023

Supplementary notes

Figures are for U.S. R&D-stage companies.
* Added from previous editions of the same report.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Initial public offerings (IPOs) in the United States "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Initial public offerings (IPOs) in the United States

Global overview

5

IPOs in the U.S.

7

Size of IPOs

4

Post-IPO

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.